These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 603666)

  • 21. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 22. Superiority of bromocriptine over pyridoxine in the treatment of patients with acromegaly or galactorrhea.
    Blum I; Segal S; Kaufman H; Sagiv M; Shalit M; Chowers I
    Isr J Med Sci; 1980 Jan; 16(1):12-6. PubMed ID: 7188934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of bromocriptine (CB-154) in diabetes associated with acromegaly].
    Sakai Y; Nagasaka A; Makino H
    Horumon To Rinsho; 1977 Dec; 25(12):1323-6. PubMed ID: 598034
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term bromocriptine treatment and somatostatin in acromegaly.
    Gáspár L; László FA
    Endokrinologie; 1980 Oct; 76(2):152-62. PubMed ID: 6108852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term use of parlodel in acromegaly].
    Pisarskaia IV; Zefirova GS; Ibragimova GV
    Ter Arkh; 1984; 56(10):107-10. PubMed ID: 6523351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of acromegaly with dopamine agonists.
    Jaffe CA; Barkan AL
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):713-35. PubMed ID: 1355728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of response to bromocriptine in acromegaly.
    Atkinson AB; Trimble ER; Hadden DR; Sheridan B
    Ulster Med J; 1978; 47(1):73-8. PubMed ID: 653899
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug therapy of hypophyseal tumors].
    Althoff PH; Schöffling K
    Internist (Berl); 1985 May; 26(5):280-92. PubMed ID: 3924851
    [No Abstract]   [Full Text] [Related]  

  • 29. [Long-term treatment of acromegaly with bromocriptine (Parlodel R)].
    Dolecek R; Závada M
    Vnitr Lek; 1977 Sep; 23(10):994-1001. PubMed ID: 411250
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug therapy of acromegaly using bromocriptine: results after a 1-year therapy].
    Benker G; Zäh W; Günnewig H; Hackenberg K; Werner U; Reinwein D
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1899-901. PubMed ID: 801096
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical results in the treatment of acromegaly with CB-154].
    Ibayashi H; Aiba H; Kato K
    Horumon To Rinsho; 1977 Dec; 25(12):1346-8. PubMed ID: 598043
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term treatment of acromegaly with lisuride: differences of effect on growth hormone and somatomedin.
    Marek J; Srámková J; Schüllerová M; Stĕpán J; Schreiberová O
    Endokrinologie; 1981 Dec; 78(2-3):175-85. PubMed ID: 7037372
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of CB-154 on acromegaly].
    Kato Y; Iwasaki Y; Chihara K; Imura H
    Horumon To Rinsho; 1977 Dec; 25(12):1332-6. PubMed ID: 598038
    [No Abstract]   [Full Text] [Related]  

  • 34. Bromocriptine treatment of acromegaly: possible dose dependency of the tumor size-reducing effect.
    Gross DJ; Halperin Y; Gomori JM; Glaser B
    Isr J Med Sci; 1989 May; 25(5):256-60. PubMed ID: 2498229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bromoergocriptine and growth hormone (GH) dynamics in health and hypersomatotropism.
    Sachdev Y
    J Assoc Physicians India; 1983 Apr; 31(4):195-9. PubMed ID: 6417104
    [No Abstract]   [Full Text] [Related]  

  • 36. [CB-154 in the treatment of acromegaly: conclusion].
    Shizume K; Demura R
    Horumon To Rinsho; 1977 Dec; 25(12):1349-53. PubMed ID: 598044
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term therapy of acromegaly and gigantism by using CB-154].
    Aizawa T; Tawada M; Koizumi Y; Ikejiri K; Kotani M
    Horumon To Rinsho; 1977 Dec; 25(12):1310-5. PubMed ID: 598032
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic experience with CB-154 in acromegaly].
    Abe K; Shigemasa C; Takeda A; Ikeda T; Kitahara K
    Horumon To Rinsho; 1977 Dec; 25(12):1338-40. PubMed ID: 598040
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
    Molinatti GM; Camanni F; Massara F; Isaia GC
    Panminerva Med; 1975 Apr; 17(4):101-6. PubMed ID: 1153217
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of CB-154 administration in acromegaly].
    Nakagawa K; Obara T
    Horumon To Rinsho; 1977 Dec; 25(12):1274-6. PubMed ID: 598017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.